Metabotropic Glutamate Receptor Market Report: Trends, Forecast and Competitive Analysis to 2030

Metabotropic Glutamate Receptor Trends and Forecast

The future of the global metabotropic glutamate receptor market looks promising with opportunities in the attention deficit hyperactivity disorder (ADHD), alzheimer's disease, and chronic obstructive pulmonary disease (COPD) markets. The global metabotropic glutamate receptor market is expected to reach an estimated $2.3 billion by 2030 with a CAGR of 11.0% from 2024 to 2030. The major drivers for this market are increase in the prevalence of neurological conditions, growth in disposable income and rise in the world's elderly population.

A more than 150-page report is developed to help in your business decisions.

Metabotropic Glutamate Receptor by Segment

The study includes a forecast for the global metabotropic glutamate receptor by product type, application, and region.

Metabotropic Glutamate Receptor Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• mGluR2
• mGluR4
• mGluR5

Metabotropic Glutamate Receptor Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Attention Deficit Hyperactivity Disorder
• Alzheimer's Disease
• Chronic Obstructive Pulmonary Disease

Metabotropic Glutamate Receptor Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• Europe
• Asia Pacific
• ROW

List of Metabotropic Glutamate Receptor Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies metabotropic glutamate receptor companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the metabotropic glutamate receptor companies profiled in this report include-

• Eli Lilly and Company
• Novartis International
• Prexton Therapeutics
• Addex Therapeutics
• Taisho Pharmaceutical Holding
• Astrazeneca
• Domain Therapeutic
• Abcam
• Johnson & Johnson
• Medgenic

Metabotropic Glutamate Receptor Market Insights

Lucintel forecasts that mGlur5 is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to existence of well-established healthcare infrastructure, rise in research funding, huge patient pool suffering from neurological disorders in the region.

Features of the Global Metabotropic Glutamate Receptor Market

Market Size Estimates: Metabotropic glutamate receptor market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Metabotropic glutamate receptor market size by product type, application, and region in terms of value ($B).

Regional Analysis: Metabotropic glutamate receptor market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, application, and regions for the metabotropic glutamate receptor market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the metabotropic glutamate receptor market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the metabotropic glutamate receptor market size?

Answer: The global metabotropic glutamate receptor market is expected to reach an estimated $2.3 billion by 2030.

Q.2 What is the growth forecast for metabotropic glutamate receptor market?

Answer: The global metabotropic glutamate receptor market is expected to grow with a CAGR of 11.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the metabotropic glutamate receptor market?

Answer: The major drivers for this market are increase in the prevalence of neurological conditions, growth in disposable income and rise in the world's elderly population.

Q4. What are the major segments for metabotropic glutamate receptor market?

Answer: The future of the global metabotropic glutamate receptor market looks promising with opportunities in the attention deficit hyperactivity disorder (ADHD), alzheimer's disease, and chronic obstructive pulmonary disease (COPD) markets.

Q5. Who are the key metabotropic glutamate receptor market companies?

Answer: Some of the key metabotropic glutamate receptor companies are as follows.

• Eli Lilly and Company
• Novartis International
• Prexton Therapeutics
• Addex Therapeutics
• Taisho Pharmaceutical Holding
• Astrazeneca
• Domain Therapeutic
• Abcam
• Johnson & Johnson
• Medgenic

Q6. Which metabotropic glutamate receptor market segment will be the largest in future?

Answer: Lucintel forecasts that mGlur5 is expected to witness highest growth over the forecast period.

Q7. In metabotropic glutamate receptor market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of well-established healthcare infrastructure, rise in research funding, huge patient pool suffering from neurological disorders in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the metabotropic glutamate receptor market by product type (mGlur2, mGlur4, and mGlur5), application (attention deficit hyperactivity disorder, alzheimer's disease, and chronic obstructive pulmonary disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?